Mito-stress Assay

The assay first records respiration under baseline conditions, then adds oligomycin to inhibit ATP synthase. The resulting change in oxygen consumption represents respiration linked to ATP production, while the remaining signal reflects other respiratory activity. This separation helps determine how strongly cellular oxygen use is associated with energy generation through oxidative phosphorylation.

FCCP uncouples oxidative phosphorylation, allowing the assay to measure maximal respiratory capacity rather than ATP-linked oxygen use alone. Comparing this response with baseline respiration indicates how much respiratory performance is available under uncoupled conditions. In neuroscience experiments, that comparison can show whether neuronal or glial mitochondria respond differently when energy demand is assessed beyond their basal state.

Rotenone and antimycin A block electron transport, providing a final reference for oxygen consumption that does not arise from mitochondrial electron transport. Subtracting this non-mitochondrial component from earlier measurements improves interpretation of basal, ATP-linked, and maximal respiratory signals. This step is especially useful when comparing mitochondrial function across experimental cell states.

The sequence creates progressively different functional conditions within the same measurement. Baseline respiration is recorded first, oligomycin then isolates the ATP synthase-linked contribution, FCCP tests maximal respiratory capacity, and the final inhibitors identify non-mitochondrial oxygen consumption. Preserving this order allows the separate respiratory components to be calculated from linked changes in oxygen consumption.

Cells are measured for oxygen consumption under controlled conditions before compounds are introduced sequentially. Oligomycin is added first, followed by FCCP, and then rotenone with antimycin A. The oxygen-consumption responses from each stage are recorded and used to distinguish basal respiration, ATP-linked respiration, maximal respiratory capacity, and non-mitochondrial consumption.

The assay yields several functionally distinct indicators rather than one overall respiration value. Basal respiration describes oxygen use before perturbation, ATP-linked respiration reflects the portion affected by ATP synthase inhibition, maximal respiratory capacity follows uncoupling, and non-mitochondrial oxygen consumption remains after electron-transport blockade. Together, these measures provide a structured profile of cellular energy metabolism.

Neuroscience researchers can apply the Mito-stress Assay to characterize bioenergetics in neuronal and glial cells, examine mitochondrial dysfunction, and test how disease-related changes alter energy metabolism. It also supports evaluation of experimental treatments by showing whether those conditions change basal respiration, ATP-linked activity, maximal capacity, or non-mitochondrial oxygen consumption.

Comparing the separate respiratory parameters across conditions can reveal which part of energy metabolism has changed. A difference in basal respiration may not have the same meaning as a change after oligomycin or FCCP, because those stages probe different functional components. This profile helps relate disease-associated or treatment-related effects to specific aspects of neuronal or glial bioenergetics.